Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Gredmark-Russ

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Plos Neglected Tropical Diseases|February 28, 2025
Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohortDavid Wullimann, John Tyler Sandberg, Mira Akber, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 12, 2026
Diagnostic value of RT-PCR for detection of tick-borne encephalitis virus RNA in cerebrospinal fluidHedvig Glans, Sofia Bartholdsson, Nina Lagerqvist, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 12, 2020
Magnitude and Functional Profile of the Human CD4<sup>+</sup> T Cell Response throughout Primary Immunization with Tick-Borne Encephalitis Virus VaccineRenata Varnaitė, Kim Blom, Margit H Lampen, et al.
Journal of Clinical Immunology|April 27, 2024
Severe Tick-Borne Encephalitis (TBE) in a Patient with X-Linked Agammaglobulinemia; Treatment with TBE Virus IgG Positive Plasma, Clinical Outcome and T Cell ResponsesWilhelm Hedin, Peter Bergman, Mily Akhirunessa, et al.
Plos Neglected Tropical Diseases|February 9, 2023
Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trialJohn Tyler Sandberg, Marie Löfling, Renata Varnaitė, et al.
Immunity|July 25, 2023
Graded expression of the chemokine receptor CX3CR1 marks differentiation states of human and murine T cells and enables cross-species interpretationAnthonie Johan Zwijnenburg, Jyoti Pokharel, Renata Varnaitė, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2016
NK Cell Responses to Human Tick-Borne Encephalitis Virus InfectionKim Blom, Monika Braun, Jolita Pakalniene, et al.
The Journal of Infectious Diseases|September 24, 2024
Clinical Characteristics of Tick-Borne Encephalitis in Adult Patients: A 10-year Retrospective Study in Stockholm, SwedenSofia Bartholdsson, Maria-Pia Hergens, Karin E Hansson, et al.
Frontiers in Immunology|October 16, 2018
Cell-Mediated Immune Responses and Immunopathogenesis of Human Tick-Borne Encephalitis Virus-InfectionKim Blom, Angelica Cuapio, J Tyler Sandberg, et al.
Open Forum Infectious Diseases|November 13, 2025
Mpox-Specific Neutralizing Antibodies up to 9 Months Following 1 or 2 Doses of Intradermal MVA-BN Vaccination in SwedenCarmen Espinosa-Gongora, Wanda Christ, Núria Mayola Danés, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Plos Neglected Tropical Diseases|February 28, 2025
Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohortDavid Wullimann, John Tyler Sandberg, Mira Akber, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 12, 2026
Diagnostic value of RT-PCR for detection of tick-borne encephalitis virus RNA in cerebrospinal fluidHedvig Glans, Sofia Bartholdsson, Nina Lagerqvist, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 12, 2020
Magnitude and Functional Profile of the Human CD4<sup>+</sup> T Cell Response throughout Primary Immunization with Tick-Borne Encephalitis Virus VaccineRenata Varnaitė, Kim Blom, Margit H Lampen, et al.
Journal of Clinical Immunology|April 27, 2024
Severe Tick-Borne Encephalitis (TBE) in a Patient with X-Linked Agammaglobulinemia; Treatment with TBE Virus IgG Positive Plasma, Clinical Outcome and T Cell ResponsesWilhelm Hedin, Peter Bergman, Mily Akhirunessa, et al.
Plos Neglected Tropical Diseases|February 9, 2023
Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trialJohn Tyler Sandberg, Marie Löfling, Renata Varnaitė, et al.
Immunity|July 25, 2023
Graded expression of the chemokine receptor CX3CR1 marks differentiation states of human and murine T cells and enables cross-species interpretationAnthonie Johan Zwijnenburg, Jyoti Pokharel, Renata Varnaitė, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2016
NK Cell Responses to Human Tick-Borne Encephalitis Virus InfectionKim Blom, Monika Braun, Jolita Pakalniene, et al.
The Journal of Infectious Diseases|September 24, 2024
Clinical Characteristics of Tick-Borne Encephalitis in Adult Patients: A 10-year Retrospective Study in Stockholm, SwedenSofia Bartholdsson, Maria-Pia Hergens, Karin E Hansson, et al.
Frontiers in Immunology|October 16, 2018
Cell-Mediated Immune Responses and Immunopathogenesis of Human Tick-Borne Encephalitis Virus-InfectionKim Blom, Angelica Cuapio, J Tyler Sandberg, et al.
Open Forum Infectious Diseases|November 13, 2025
Mpox-Specific Neutralizing Antibodies up to 9 Months Following 1 or 2 Doses of Intradermal MVA-BN Vaccination in SwedenCarmen Espinosa-Gongora, Wanda Christ, Núria Mayola Danés, et al.
Pageof 4